Navigation Links
Bioreactor for bone tissue engineering wins professor venture fair
Date:11/19/2009

hair in the department of chemistry and biochemistry;
  • "Sense-HER: A Low-Cost, Electronic Breast Cancer Gene Detection System," R.D. Gomez and Konrad Aschenbach, both of the department of electrical and computer engineering;
  • "Manipulation of Guard Cells: Drought-Tolerant Plants for Feeding the World's Hungry," June Kwak, assistant professor in the department of cell biology amd molecular genetics;
  • "Cold Adapted/Temperature Sensitive Live Attenuated Avian Influenza Vaccines for Poultry, Livestock, and Humans," Daniel Perez, associate professor in the department of veterinary medicine; and
  • "Super Fiber for Human Health," Lucy Yu, professor in the department of nutrition and food science.

    The annual Biotechnology Research and Technology Review Day Professor Venture Fair is hosted by the Maryland Technology Enterprise Institute (Mtech), the Office of Technology Commercialization, and the College of Chemical and Life Sciences. The pitch competition encourages scientists to consider the commercial potential of their work and challenges them to translate their ideas to a general, non-technical audience.

    This year's Professor Venture Fair was sponsored by the Maryland Technology Development Corporation (TEDCO).

    Both past winners in the fair's relatively brief, three-year history have gone on to create successful start-up companies. Last year's winner, Matt Dowling, had already started Remedium Technologies in 2007, and the company, now in the Mtech VentureAccelerator Program, continues to develop its Velcro-like biomaterial bandages.

    Lawrence Sita, the 2007 winner, started Precision Polyolefins, a company that could revolutionize the plastics industry by introducing a clean alternative to existing methods of plastics production.

    "Investors can find it difficult to navigate the wealth of research at universities to pinpoint a major market winner," says Dean Chang, director of Mtech's venture and
    '/>"/>


  • Contact: Eric Schurr
    schurr@umd.edu
    301-405-3889
    University of Maryland
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
    2. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
    3. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
    4. For young boys with cancer, testicular tissue banking may be option to preserve fertility
    5. A major step in making better stem cells from adult tissue
    6. National Institutes of Health award Clemson $9.3 million for tissue regeneration center
    7. KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
    8. University of Miami receives NIH grant to support novel technology for tissue engineering
    9. Green tea component may help preserve stored platelets, tissues
    10. Researcher says microchannels could advance tissue engineering methods
    11. Skin-like tissue developed from human embryonic stem cells
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
    (Date:3/23/2015)... BOSTON, Mass , March 23, 2015 SoundView ... shipment of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView ... world user feedback on their experience with the Wocket in ... experience at CVS, Whole Foods and other retailers, making both ... Kris Tuttle also says, "If the company meets ...
    (Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
    Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
    ... come out of research conducted on the edge of ... Olduvai Gorge in Tanzania since that produced by Louis ... a special issue of the prestigious Journal of ... of the Bernard Price Institute for Palaeontological Research, and ...
    ... on a unique vertebrate called the sea lamprey shows that ... development. These genes are paradoxically lost all throughout the developing ... or PGCs. The PGCs can be thought of as embryonic ... generation of lampreys. Based on computational analysis, a significant number ...
    ... rapidly create healthy clots and nearly double the survival ... research shows. "We knew an injection of these ... bleeding is stopped in time to increase survival following ... at Case Western Reserve University and leader of the ...
    Cached Biology News:Dawn of humanity illuminated in special journal edition - 50 years after the Leakeys 2Research reveals unique solution to gene regulation 2Nanoparticles added to platelets double internal injury survival rate 2
    (Date:3/27/2015)... March 27, 2015 WuXi PharmaTech (Cayman) ... R&D capability and technology platform company serving the ... today that an Investigational New Drug (IND) application ... rheumatoid arthritis has been accepted for review by ... In September 2012, MedImmune, the global ...
    (Date:3/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... including the appointment of auditors, its annual and special ... "Meeting") was adjourned, as previously disclosed on March 25, ... Toronto time). The date of the ... The Meeting will reconvene at the offices of the ...
    (Date:3/26/2015)... BOSTON , March 26, 2015 /PRNewswire/ ... ), a global clinical research organization ... signed a definitive agreement to acquire all ... India ("QSI"), a leading provider of specialized ... refers to the collection, detection, assessment, monitoring, ...
    (Date:3/25/2015)... pharmaceutical market is one of the most ... its absolute size, plus a growing economy and increasing ... Business Monitor International. The Russian market is set to ... market, with growth estimates around 10-15% annually reaching an ... About Green Cross Green Cross provides ...
    Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3SQI Diagnostics Inc. Announces Adjournment of Meeting 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4
    ... SAN DIEGO, March 25 ADVENTRX Pharmaceuticals, Inc. (NYSE ... for the fourth quarter and year ended December 31, ... we advanced a new business model focused on lower-risk ... our new lead programs, but given the difficult economic ...
    ... RICHMOND, Va., March 25 Insmed Inc. (Nasdaq: ... today announced that on Monday, March 23, 2009, NASDAQ issued ... a minimum $1 closing bid price and those rules requiring ... The suspension will remain in effect through Friday, July 17, ...
    ... - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ... enrolment in its U.K. clinical trial to evaluate ... in combination with gemcitabine (Gemzar(R)) in patients with ... The principal investigators are Dr. Johann de Bono ...
    Cached Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 7Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
    Request Info...
    ... 2 , Maintenance 112 days/each ... , Immunizations/Boost injections x5 /each ... /each , Production bleed (25 ml ... Bleed ~ 100 ml blood (~50 ml serum) x1 ...
    FluoSpheres® biotin-labeled microspheres, 1.0 µm, yellow-green fluorescent (505/515) *1% solids*...
    chk 1 kinase...
    Biology Products: